{"ORPHApacket":[{"ORPHApacketID":"213610","date":"2019-12-06 00:21:15","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"213610","Name":[{"lang":"en","label":"Carcinosarcoma of the corpus uteri"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213610","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Malignant mixed epithelial and mesenchymal tumor of corpus uteri"}],"ORPHA":"213589","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213589"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Carcinosarcoma of the corpus uteri is a rare, malignant, mixed epithelial and mesenchymal tumor of the uterine body composed of high-grade carcinomatous and sarcomatous elements. It may present with vaginal bleeding, abnormal vaginal discharge, abdominal pain and\/or pelvic mass, with a polypoid tumor sometimes protruding through the cervical canal. Association with Tamoxifen therapy, long-term unopposed estrogen use and previous pelvic radiotherapy has been reported."}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Malignant mixed M\u00c3\u00bcllerian tumor of the corpus uteri"},{"lang":"en","label":"Mixed M\u00c3\u00bcllerian cancer of corpus uteri"},{"lang":"en","label":"Uterine carcinosarcoma"}]}]}]}